Haemonetics Corporation drugs
14 results
As-3 (as-3)
(AS-3)Haemonetics Corporation
Cpda-1 blood collection system (blood collection system)
(Blood Collection System)Haemonetics Corporation
Usage: This drug is indicated for the collection of blood and the preparation of red blood cells, plasma, and platelets, though it is not intended to produce platelets when using 'doubles.'
Cpda-1 blood collection system (blood collection system)
(Blood Collection System)Haemonetics Corporation
Usage: This drug is indicated for the collection of blood and the preparation of red blood cells, plasma, and platelets. Note that platelets are not intended for production when using the 'doubles' method.
Haemonetics additive solution formula 3 (as-3) (citric acid monohydrate, sodium phosphate, monobasic, monohydrate, sodium chloride, adenine, anhydrous dextrose, trisodium citrate dihydrate)
(CITRIC ACID MONOHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM CHLORIDE, ADENINE, ANHYDROUS DEXTROSE, TRISODIUM CITRATE DIHYDRATE)Haemonetics Corporation
Usage: The Haemonetics CP2D anticoagulant and AS-3 additive solution are used with automated apheresis devices for collecting human blood components. CP2D prevents clotting, while AS-3 maintains red blood cell viability during storage. They are not for direct infusion into donors and do not serve as storage containers.
Haemonetics anticoagulant citrate phosphate double dextrose solution (cp2d) (citric acid monohydrate, trisodium citrate dihydrate, sodium phosphate, monobasic, monohydrate, anhydrous dextrose)
(CITRIC ACID MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, ANHYDROUS DEXTROSE)Haemonetics Corporation
Usage: The Haemonetics CP2D and AS-3 solutions are used with automated apheresis devices to collect human blood components. CP2D serves as an anticoagulant, while AS-3 maintains red blood cell viability for 42 days and is utilized in red blood cell washing processes.
Haemonetics anticoagulant sodium citrate (trisodium citrate dihydrate)
(TRISODIUM CITRATE DIHYDRATE)Haemonetics Corporation
Leukotrap - as-3 (as-3)
(AS-3)Haemonetics Corporation
Leukotrap - cp2d (anticoagulant citrate phosphate double dextrose)
(ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE)Haemonetics Corporation
Leukotrap wb system (cpda-1 blood bag collection system)
(CPDA-1 Blood Bag Collection System)Haemonetics Corporation
Usage: This drug is indicated for the collection of blood and the preparation of red blood cells and plasma with pre-storage leukocyte reduction. It is not intended for the preparation of platelet concentrates.
Leukotrap wb system (cpda-1 blood bag collection system)
(CPDA-1 Blood Bag Collection System)Haemonetics Corporation
Usage: This drug is indicated for the collection of blood and preparation of red blood cells and plasma with pre-storage leukocyte reduction. It is not intended for the production of platelet concentrates.